Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intracavernous self-injection in impotence].

A Sieber1, M Schnyder von Wartensee, H J Thönen

  • 1Urologische Universitätsklinik, Inselspital, Bern.

Therapeutische Umschau. Revue Therapeutique
|January 1, 1992
PubMed
Summary

Intracavernous self-injection of papaverine normalized erectile function in 11% of impotent men. While 25% continued treatment, many found this erectile dysfunction therapy unacceptable, highlighting the need for early patient counseling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the genetic architecture and the potential of genomics-assisted breeding of quality traits in two large panels of durum wheat.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2019
Same author

Zero fluid balance and normotension prevents complications, not the amount of fluid per se.

World journal of urology·2018
Same author

[In Process Citation].

Aktuelle Urologie·2015
Same author

Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Indications for continent diversion after cystectomy and factors affecting long-term results.

Urologic oncology·2011
Same author

The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.

Urologia internationalis·2010

Area of Science:

  • Urology
  • Andrology
  • Pharmacology

Context:

  • Erectile dysfunction (ED) affects a significant portion of the male population, with organic causes identified in 50-80% of cases.
  • Intracavernous self-injection (ICSI) therapy using papaverine is a treatment option for ED.
  • Patient acceptance and adherence to ICSI therapy can be variable.

Purpose:

  • To evaluate the efficacy and patient acceptance of intracavernous self-injection therapy with papaverine in a large cohort of men with erectile dysfunction.
  • To assess the long-term outcomes and side effects associated with papaverine ICSI therapy.
  • To determine the impact of early physician counseling on patient adherence to ED treatments.

Summary:

  • A study involving 409 patients with erectile dysfunction investigated the outcomes of papaverine ICSI therapy.

Related Experiment Videos

  • Erectile function was normalized in 11% of patients post-treatment, and 25% continued regular home use.
  • A significant majority (64%) discontinued therapy, often due to lack of acceptance, though side effects were minimal.

    • Impact:

    • Results suggest that while papaverine ICSI can be effective for some, patient acceptance remains a challenge in erectile dysfunction management.
    • Early and comprehensive information from physicians regarding ICSI therapy may improve patient selection and reduce unnecessary investigations.
    • This study underscores the importance of patient counseling in optimizing treatment outcomes for erectile dysfunction.